Select Medical (NYSE:SEM) Upgraded to Buy at StockNews.com

Select Medical (NYSE:SEM) was upgraded by StockNews.com from a “hold” rating to a “buy” rating in a research report issued on Monday.

SEM has been the subject of a number of other reports. Benchmark cut shares of Select Medical from a “buy” rating to a “hold” rating in a report on Monday, November 25th. Royal Bank of Canada boosted their price target on shares of Select Medical from $40.00 to $47.00 and gave the stock an “outperform” rating in a report on Monday, November 4th. Finally, UBS Group reduced their price objective on Select Medical from $40.00 to $21.00 and set a “neutral” rating for the company in a report on Friday, January 3rd. Two equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $39.50.

Select Medical Price Performance

Select Medical stock opened at $20.36 on Monday. The stock has a 50-day moving average price of $20.98 and a two-hundred day moving average price of $30.23. The company has a market capitalization of $2.64 billion, a PE ratio of 9.51, a P/E/G ratio of 0.65 and a beta of 1.45. Select Medical has a 12 month low of $18.02 and a 12 month high of $40.98. The company has a current ratio of 1.13, a quick ratio of 1.13 and a debt-to-equity ratio of 1.37.

Select Medical (NYSE:SEM) last announced its earnings results on Thursday, October 31st. The health services provider reported $0.43 EPS for the quarter, topping the consensus estimate of $0.36 by $0.07. The firm had revenue of $1.76 billion for the quarter, compared to the consensus estimate of $1.74 billion. Select Medical had a return on equity of 15.99% and a net margin of 3.97%. The business’s quarterly revenue was up 5.7% compared to the same quarter last year. During the same period in the previous year, the business earned $0.46 EPS. Analysts expect that Select Medical will post 1.97 EPS for the current year.

Insider Buying and Selling

In other Select Medical news, Director Marilyn B. Tavenner sold 32,000 shares of the company’s stock in a transaction on Tuesday, November 26th. The shares were sold at an average price of $21.09, for a total value of $674,880.00. Following the completion of the transaction, the director now directly owns 22,000 shares in the company, valued at approximately $463,980. This represents a 59.26 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, VP Robert G. Breighner, Jr. sold 4,989 shares of the firm’s stock in a transaction that occurred on Wednesday, December 4th. The shares were sold at an average price of $19.95, for a total value of $99,530.55. Following the completion of the transaction, the vice president now owns 30,356 shares of the company’s stock, valued at approximately $605,602.20. The trade was a 14.12 % decrease in their position. The disclosure for this sale can be found here. 19.14% of the stock is owned by insiders.

Institutional Investors Weigh In On Select Medical

Several hedge funds have recently added to or reduced their stakes in SEM. Quarry LP bought a new stake in shares of Select Medical in the 3rd quarter worth $30,000. Canada Pension Plan Investment Board bought a new position in Select Medical in the second quarter worth approximately $39,000. GAMMA Investing LLC lifted its position in Select Medical by 16.6% during the third quarter. GAMMA Investing LLC now owns 2,313 shares of the health services provider’s stock valued at $81,000 after purchasing an additional 330 shares in the last quarter. Wilmington Savings Fund Society FSB purchased a new position in shares of Select Medical during the 3rd quarter valued at about $81,000. Finally, Mount Yale Investment Advisors LLC bought a new position in shares of Select Medical in the third quarter worth approximately $193,000. 89.48% of the stock is owned by institutional investors.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.